Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionAusdal Financial Partners, Inc.
Latest Disclosed Ownership5,230 shares
Latest Disclosed Value $ 1,840,127
Ausdal Financial Partners, Inc. reports 24.43% increase in ownership of AMGN / Amgen Inc.

On May 12, 2026 - Ausdal Financial Partners, Inc. filed a 13F-HR form disclosing ownership of 5,230 shares of Amgen Inc. (CH:AMGN) valued at $1,840,127 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,203 shares of Amgen Inc.. This represents a change in shares of 24.43% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AMGEN COM 031162100 5,230 1,027 24.43 1,840 33.82 0.0818
2026-02-13 2025-12-31 13F AMGEN COM 031162100 4,203 896 27.09 1,376 47.37 0.0638
2025-11-14 2025-09-30 13F AMGEN COM 031162100 3,307 801 31.96 933 33.48 0.0453
2025-08-14 2025-06-30 13F AMGEN COM 031162100 2,506 -557 -18.18 700 -26.73 0.0467
2025-05-15 2025-03-31 13F AMGEN COM 031162100 3,063 554 22.08 954 46.09 0.0719
2025-02-12 2024-12-31 13F AMGEN COM 031162100 2,509 1,008 67.16 654 35.20 0.0565
2024-10-04 2024-09-30 13F AMGEN COM 031162100 1,501 -24 -1.57 483 1.47 0.0502
2024-08-06 2024-06-30 13F AMGEN COM 031162100 1,525 -159 -9.44 476 -0.42 0.0509
2024-04-12 2024-03-31 13F AMGEN COM 031162100 1,684 -518 -23.52 479 -24.61 0.0556
2024-01-11 2023-12-31 13F AMGEN COM 031162100 2,202 -519 -19.07 634 -13.27 0.0785
2023-11-08 2023-09-30 13F AMGEN COM 031162100 2,721 525 23.91 731 50.10 0.1007
2023-07-31 2023-06-30 13F AMGEN COM 031162100 2,196 -29 -1.30 488 -9.31 0.0663
2023-05-04 2023-03-31 13F AMGEN COM 031162100 2,225 -33 -1.46 538 -9.44 0.0741
2023-02-03 2022-12-31 13F AMGEN COM 031162100 2,258 96 4.44 593 21.77 0.0862
2022-11-09 2022-09-30 13F AMGEN COM 031162100 2,162 99 4.80 487 -2.99 0.0768
2022-08-09 2022-06-30 13F AMGEN COM 031162100 2,063 85 4.30 502 5.02 0.0758
2022-05-04 2022-03-31 13F AMGEN COM 031162100 1,978 404 25.67 478 35.03 0.0650
2022-02-08 2021-12-31 13F AMGEN COM 031162100 1,574 392 33.16 354 41.04 0.0473
2021-11-01 2021-09-30 13F AMGEN COM 031162100 1,182 131 12.46 251 -1.95 0.0373
2021-07-19 2021-06-30 13F AMGEN COM 031162100 1,051 -22 -2.05 256 -4.12 0.0387
2021-05-05 2021-03-31 13F AMGEN COM 031162100 1,073 65 6.45 267 15.09 0.0451
2021-02-01 2020-12-31 13F AMGEN COM 031162100 1,008 -91 -8.28 232 -16.85 0.0452
2020-11-04 2020-09-30 13F AMGEN COM 031162100 1,099 62 5.98 279 13.88 0.0675
2020-08-06 2020-06-30 13F AMGEN COM 031162100 1,037 0 0.00 245 0.00 0.0811
2020-05-04 2020-03-31 13F AMGEN COM 031162100 1,037 -1,114 -51.79 245 -49.90 0.0866
2020-02-14 2019-12-31 13F AMGEN COM 031162100 2,151 13 0.61 489 18.12 0.1449
2019-11-19 2019-09-30 13F AMGEN COM 031162100 2,138 -19 -0.88 414 8.66 0.1465
2019-08-05 2019-06-30 13F AMGEN COM 031162100 2,157 -544 -20.14 381 -25.73 0.1462
2019-05-13 2019-03-31 13F AMGEN COM 031162100 2,701 117 4.53 513 1.99 0.2087
2019-02-11 2018-12-31 13F AMGEN COM 031162100 2,584 -1,194 -31.60 503 -35.76 0.2456
2018-11-09 2018-09-30 13F AMGEN COM 031162100 3,778 68 1.83 783 14.31 0.2206
2018-08-08 2018-06-30 13F AMGEN COM 031162100 3,710 -278 -6.97 685 0.74 0.2115
2018-04-20 2018-03-31 13F AMGEN COM 031162100 3,988 232 6.18 680 4.13 0.2362
2018-02-08 2017-12-31 13F AMGEN COM 031162100 3,756 166 4.62 653 -2.39 0.2340
2017-11-13 2017-09-30 13F/A-1 AMGEN COM 031162100 3,590 -611 -14.54 669 -7.60 0.2655
2017-10-31 2017-09-30 13F AMGEN COM 031162100 3,590 -611 669 0.2671
2017-08-11 2017-06-30 13F AMGEN COM 031162100 4,201 705 20.17 724 26.13 0.3092
2017-08-11 2017-03-31 13F/A-2 AMGEN COM 031162100 3,496 235 7.21 574 20.34 0.2585
2017-05-01 2017-03-31 13F AMGEN COM 031162100 3,261 0 477 0.2239
2017-01-23 2016-12-31 13F AMGEN COM 031162100 3,261 99 3.13 477 -9.49 0.2236
2016-10-25 2016-09-30 13F AMGEN COM 031162100 3,162 61 1.97 527 11.65 0.2656
2016-07-29 2016-06-30 13F AMGEN COM 031162100 3,101 -260 -7.74 472 -6.35 0.2422
2016-05-05 2016-03-31 13F AMGEN COM 031162100 3,361 156 4.87 504 -3.08 0.2862
2016-02-17 2015-12-31 13F AMGEN COM 031162100 3,205 3,205 520 0.2629
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.